How much does it cost to buy Vericigua in Hunan? What is the correct dosage of Vericiguat?

Vericiguat, an oral soluble guanylate cyclase (sGC) modulator, will be launched in the United States in 2021. It can regulate endothelial function and myocardial energy metabolism through the nitric oxide cyclic guanosine monophosphate signaling pathway (NO-sGC-cGMP), improving the prognosis of HF patients. The drug is currently approved for the treatment of chronic heart failure with reduced ejection fraction (HFrEF).

So, how much does it cost to buy Vilicigua in Hunan?

At present, the domestic marketing application of Veciguat is still under review. The product is temporarily unavailable in domestic hospital pharmacies. Patients in Hunan and other parts of the country need to go abroad to purchase Veciguat. However, this imposes a heavy financial burden and there is no guarantee that what they are buying is genuine. It is recommended that patients learn about overseas Viliciguat through Medical Companion Travel, which is directly mailed from the pharmaceutical factory. It is affordable and cost-effective, and is suitable for patients to take medicine for a long time. The drugs obtained through Medical Companion Travel are guaranteed to be genuine, and a guarantee contract is signed with the patient, so the patient can purchase the drug with confidence. For specific information on the price of the overseas drug Veliciguat and the process of purchasing the drug, patients can consult the medical companion and travel service staff.

So, what is the correct usage and dosage of Veliciguat?

Vericiguat is an oral medication with a recommended starting dose of 2.5 mg taken daily with food. For patients who have difficulty swallowing, the tablets may be crushed and mixed with water. The dose of veliciguat should be doubled approximately every 2 weeks to achieve the patient's target maintenance dose of 10 mg per day. The main specifications of vericiguat are 2.5 mg; 5 mg; 10 mg. Patients must read the dosage carefully when taking the medicine. They must not increase or decrease the dosage at will and must follow the doctor's instructions. Vericiguat is the first soluble guanylate cyclase (sGC) agonist to treat patients with exacerbation of chronic heart failure. It is the first new drug approved by the US FDA in 2021.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: